Logo Logo
Hilfe
Hilfe
Switch Language to English

Mele, Luigi; del Vecchio, Vitale; Liccardo, Davide; Prisco, Claudia; Schwerdtfeger, Melanie; Robinson, Nirmal; Desiderio, Vincenzo; Tirino, Virginia; Papaccio, Gianpaolo und La Noce, Marcella (2020): The role of autophagy in resistance to targeted therapies. In: Cancer Treatment Reviews, Bd. 88, 102043

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Autophagy is a self-degradative cellular process, involved in stress response such as starvation, hypoxia, and oxidative stress. This mechanism balances macro-molecule recycling to regulate cell homeostasis. In cancer, autophagy play a role in the development and progression, while several studies describe it as one of the key processes in drug resistance. In the last years, in addition to standard anti-cancer treatments such as chemotherapies and irradiation, targeted therapy became one of the most adopted strategies in clinical practices, mainly due to high specificity and reduced side effects. However, similar to standard treatments, drug resistance is the main challenge in most patients. Here, we summarize recent studies that investigated the role of autophagy in drug resistance after targeted therapy in different types of cancers. We highlight positive results and limitations of pre-clinical and clinical studies in which autophagy inhibitors are used in combination with targeted therapies.

Dokument bearbeiten Dokument bearbeiten